Literature DB >> 12684443

Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive alpha 4 nicotinic receptors.

Carlos Fonck1, Raad Nashmi, Purnima Deshpande, M Imad Damaj, Michael J Marks, Anett Riedel, Johannes Schwarz, Allan C Collins, Cesar Labarca, Henry A Lester.   

Abstract

We studied a strain of exon replacement mice ("L9'S knock-in") whose alpha4 nicotinic receptor subunits have a leucine to serine mutation in the M2 region, 9' position (Labarca et al., 2001); this mutation renders alpha4-containing receptors hypersensitive to agonists. Nicotine induced seizures at concentrations (1 mg/kg) approximately eight times lower in L9'S than in wild-type (WT) littermates. At these concentrations, L9'S but not WT showed increases in EEG amplitude and theta rhythm. L9'S mice also showed higher seizure sensitivity to the nicotinic agonist epibatidine, but not to the GABA(A) receptor blocker and proconvulsant bicuculline. Dorsiflexion of the tail (Straub tail) was the most sensitive nicotine effect found in L9'S mice (0.1 mg/kg). The L9'S mice were hypersensitive to galanthamine- and tacrine-induced seizures and Straub tails. There were no apparent neuroanatomical differences between L9'S and WT mice in several brain regions. [(125)I]Epibatidine binding to brain membranes showed that the mutant allele was expressed at approximately 25% of WT levels, presumably because of the presence of a neomycin selection cassette in a nearby intron. (86)Rb efflux experiments on brain synaptosomes showed an increased fraction of function at low agonist concentrations in L9'S mice. These data support the possible involvement of gain-of-function alpha4 receptors in autosomal dominant nocturnal frontal-lobe epilepsy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684443      PMCID: PMC6742094     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  32 in total

1.  Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR.

Authors:  M Samochocki; M Zerlin; R Jostock; P J Groot Kormelink; W H Luyten; E X Albuquerque; A Maelicke
Journal:  Acta Neurol Scand Suppl       Date:  2000

2.  Interneurons and the ghost of the sea.

Authors:  I Mody
Journal:  Nat Neurosci       Date:  1998-10       Impact factor: 24.884

3.  Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity.

Authors:  D Ji; R Lape; J A Dani
Journal:  Neuron       Date:  2001-07-19       Impact factor: 17.173

Review 4.  Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease.

Authors:  A Maelicke; M Samochocki; R Jostock; A Fehrenbacher; J Ludwig; E X Albuquerque; M Zerlin
Journal:  Biol Psychiatry       Date:  2001-02-01       Impact factor: 13.382

5.  A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.

Authors:  Y Wang; M K Spatz; K Kannan; H Hayk; A Avivi; M Gorivodsky; M Pines; A Yayon; P Lonai; D Givol
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

6.  Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety.

Authors:  C Labarca; J Schwarz; P Deshpande; S Schwarz; M W Nowak; C Fonck; R Nashmi; P Kofuji; H Dang; W Shi; M Fidan; B S Khakh; Z Chen; B J Bowers; J Boulter; J M Wehner; H A Lester
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

7.  Reduced antinociception in mice lacking neuronal nicotinic receptor subunits.

Authors:  L M Marubio; M del Mar Arroyo-Jimenez; M Cordero-Erausquin; C Léna; N Le Novère; A de Kerchove d'Exaerde; M Huchet; M I Damaj; J P Changeux
Journal:  Nature       Date:  1999-04-29       Impact factor: 49.962

8.  Nicotinic-agonist stimulated (86)Rb(+) efflux and [(3)H]epibatidine binding of mice differing in beta2 genotype.

Authors:  M J Marks; J A Stitzel; S R Grady; M R Picciotto; J P Changeux; A C Collins
Journal:  Neuropharmacology       Date:  2000-10       Impact factor: 5.250

9.  Dysfunctions in mice by NMDA receptor point mutations NR1(N598Q) and NR1(N598R).

Authors:  F N Single; A Rozov; N Burnashev; F Zimmermann; D F Hanley; D Forrest; T Curran; V Jensen; O Hvalby; R Sprengel; P H Seeburg
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

10.  Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse.

Authors:  S A Ross; J Y Wong; J J Clifford; A Kinsella; J S Massalas; M K Horne; I E Scheffer; I Kola; J L Waddington; S F Berkovic; J Drago
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

View more
  19 in total

Review 1.  Brain rhythms connect impaired inhibition to altered cognition in schizophrenia.

Authors:  Benjamin R Pittman-Polletta; Bernat Kocsis; Sujith Vijayan; Miles A Whittington; Nancy J Kopell
Journal:  Biol Psychiatry       Date:  2015-02-14       Impact factor: 13.382

Review 2.  Recent advances in gene manipulation and nicotinic acetylcholine receptor biology.

Authors:  Anne Tammimäki; William J Horton; Jerry A Stitzel
Journal:  Biochem Pharmacol       Date:  2011-06-16       Impact factor: 5.858

Review 3.  Genetic matters: thirty years of progress using mouse models in nicotinic research.

Authors:  Michael J Marks
Journal:  Biochem Pharmacol       Date:  2013-06-06       Impact factor: 5.858

Review 4.  The relevance of inter- and intrastrain differences in mice and rats and their implications for models of seizures and epilepsy.

Authors:  Wolfgang Löscher; Russell J Ferland; Thomas N Ferraro
Journal:  Epilepsy Behav       Date:  2017-06-23       Impact factor: 2.937

5.  Nicotine normalizes intracellular subunit stoichiometry of nicotinic receptors carrying mutations linked to autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  Cagdas D Son; Fraser J Moss; Bruce N Cohen; Henry A Lester
Journal:  Mol Pharmacol       Date:  2009-02-23       Impact factor: 4.436

Review 6.  Nicotinic receptor channelopathies and epilepsy.

Authors:  Ortrud K Steinlein; Daniel Bertrand
Journal:  Pflugers Arch       Date:  2009-12-17       Impact factor: 3.657

7.  Demonstration of functional alpha4-containing nicotinic receptors in the medial habenula.

Authors:  Carlos Fonck; Raad Nashmi; Ramiro Salas; Chunyi Zhou; Qi Huang; Mariella De Biasi; Robin A J Lester; Henry A Lester
Journal:  Neuropharmacology       Date:  2008-08-26       Impact factor: 5.250

Review 8.  Insights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutations.

Authors:  Ryan M Drenan; Henry A Lester
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

9.  Five ADNFLE mutations reduce the Ca2+ dependence of the mammalian alpha4beta2 acetylcholine response.

Authors:  Nivalda Rodrigues-Pinguet; Li Jia; Maureen Li; Antonio Figl; Alwin Klaassen; Anthony Truong; Henry A Lester; Bruce N Cohen
Journal:  J Physiol       Date:  2003-05-16       Impact factor: 5.182

10.  Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Koh-Ichi Tanaka; Nobuyoshi Nishiyama; Motohiko Takemura
Journal:  Brain Res       Date:  2012-09-08       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.